Vito Di Lernia

24PUBLICATIONS
117CO-AUTHORS
Clinical pharmacology and therapeuticsAdolescent healthHuman biophysicsAllergyInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Jul 25, 2026
Effectiveness and Safety of IL-17A Inhibitors in Pediatric Psoriasis: A Real-World, Multicenter, International Study.

|Jul 06, 2026
Can Systemic Treatment for Childhood Psoriasis Be Stopped in Cases of Remission? Data From the ACMe Cohort.

|Jun 12, 2026
Efficacy of Bimekizumab on Palmoplantar Psoriasis: A 16-Week Multicenter Retrospective Study-IL PSO (Italian Landscape PSOriasis).

|Feb 19, 2026
Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Emanuele Trovato, Claudio Bonifati, Simone Ribero

|Jul 04, 2025
Effectiveness and Safety of Adalimumab Biosimilars in Pediatric Psoriasis: A Multi-Center International Experience.

Cristina Bertoli, Tiago Torres, Paolo Romita

|Mar 31, 2025
Risk Assessment in Atopic Dermatitis: Guidance from a Multidisciplinary Expert Panel.

Alessandra Narcisi, Vito Di Lernia, Maria Esposito

Pageof 4

Frequent Collaborators

5 joint publications

Francesca Prignano

3 joint publications

Aldo Cuccia

3 joint publications

Emmanuel Mahé

3 joint publications

Paolo Gisondi